Maven Securities LTD Tempest Therapeutics, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.27 - $5.45 $175,645 - $421,704	-77,377 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.28 - $15.2 $261,391 - $752,491	-49,506 Reduced 39.02%	77,377 $409,000
Q3 2021 Nov 15, 2021	BUY	$10.49 - $24.19 $212,474 - $489,968	20,255 Added 19.0%	126,883 $1.84 Million
Q2 2021 Aug 16, 2021	BUY	$11.18 - $22.95 $1.19 Million - $2.45 Million	106,628 New	106,628 $1.2 Million

820K

400

Ticker TPST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,418,900
Market Cap $94.5M
Description
Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.